Review



osteoassay human bone plates  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Lonza osteoassay human bone plates
    Osteoassay Human Bone Plates, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/osteoassay+human+bone+plate/osteoassay+bone+plates/us12090249-454-26-30
    Average 90 stars, based on 1 article reviews
    osteoassay human bone plates - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Novel Bruton’s tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis
    Article Snippet: After incubation for 4 days, the cells were fixed with 10% neutral-buffered formalin and stained with using a tartrate-resistant acid phosphatase (TRAP) staining kit (Cosmo Bio, Tokyo, Japan) and DAKO REAL Hematoxylin (Dako, Glosturp, Denmark).

    Article Title: A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosis.
    Article Snippet: To cite: Ramos YFM, Bos SD, van der Breggen R, et al. Ann Rheum Dis 2015;74:1756–1762.. ABSTRACT Objective To identify pathogenic mutations that reveal underlying biological mechanisms driving osteoarthritis (OA).. Methods Exome sequencing was applied to two distant family members with dominantly inherited early onset primary OA at multiple joint sites with chondrocalcinosis (familial generalised osteoarthritis, FOA).

    Enzyme-linked Immunosorbent Assay:

    Article Title: Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption.
    Article Snippet: Bone is continuously remodelled during adulthood through the synthesis of bone matrix by osteoblasts and resorption by osteoclasts (1,2).. A balance between bone resorption and bone formation is required for the maintenance of skeletal integrity.. Imbalances between osteoblast and osteoclast activities result in skeletal disorders such as osteopetrosis, osteoporosis and inflammatory bone erosion (3,4).

    MTT Assay:

    Article Title: Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption.
    Article Snippet: Bone is continuously remodelled during adulthood through the synthesis of bone matrix by osteoblasts and resorption by osteoclasts (1,2).. A balance between bone resorption and bone formation is required for the maintenance of skeletal integrity.. Imbalances between osteoblast and osteoclast activities result in skeletal disorders such as osteopetrosis, osteoporosis and inflammatory bone erosion (3,4).

    Proliferation Assay:

    Article Title: Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption.
    Article Snippet: Bone is continuously remodelled during adulthood through the synthesis of bone matrix by osteoblasts and resorption by osteoclasts (1,2).. A balance between bone resorption and bone formation is required for the maintenance of skeletal integrity.. Imbalances between osteoblast and osteoclast activities result in skeletal disorders such as osteopetrosis, osteoporosis and inflammatory bone erosion (3,4).



    Similar Products

    90
    Lonza osteoassay human bone plates
    Osteoassay Human Bone Plates, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/osteoassay+human+bone+plate/osteoassay+bone+plates/us12090249-454-26-30
    Average 90 stars, based on 1 article reviews
    osteoassay human bone plates - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Lonza osteoassay human bone plate
    Osteoassay Human Bone Plate, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/osteoassay+human+bone+plate/osteoassay+bone+plates/pm36821545-91-18-22
    Average 90 stars, based on 1 article reviews
    osteoassay human bone plate - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Lonza osteoassay™ human bone plate
    (A-D) BMMs were treated with PP i (100-1000) μM then differentiated with RANK-L (35 ng) over human <t>OsteoAssay</t> bone chips and examined for TRAP. (A) Microscopic images show larger TRAP+ osteoclasts (arrows) and less bone chips (asterisk) in PP i -treated BMMs, compared to control. (B) TRAP activity of differentiated osteoclasts are significantly up in PP i -treated BMMs. Parameters of osteoclast function that include; Ca 2+ (C) , and CTX-1 (D) in the CM are increased in PP i -treated BMMs, compared to control. (E-H) BMMs were treated with PP i (100-1000) μM then differentiated with RANKL (35 ng) over OsteoAssay discs. (E) Microscopic images of von kossa stained discs, after removal of osteoclasts, show increased number and size of resorption pits in PP i -treated BMMs. Parameters of bone resorptions that include; number of resorption pits (N. pits) (F) , total resorption area (Tt. Ar) (G) , and average pit size per osteoclast (pit Ar) are higher in PP i -treated BMMs, compared to control. Experiments were repeated at least 3 times and showed similar results. N= 6 per group. N= 6 per group. The Mean value is represented in all graphs + SEM. *, p < 0.05; **, p < 0.01. Scale bars , 200 μm.
    Osteoassay™ Human Bone Plate, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/osteoassay+human+bone+plate/osteoassay+bone+plates/bio_rxiv__2020__10__01__321976-114-8-12
    Average 90 stars, based on 1 article reviews
    osteoassay™ human bone plate - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A-D) BMMs were treated with PP i (100-1000) μM then differentiated with RANK-L (35 ng) over human OsteoAssay bone chips and examined for TRAP. (A) Microscopic images show larger TRAP+ osteoclasts (arrows) and less bone chips (asterisk) in PP i -treated BMMs, compared to control. (B) TRAP activity of differentiated osteoclasts are significantly up in PP i -treated BMMs. Parameters of osteoclast function that include; Ca 2+ (C) , and CTX-1 (D) in the CM are increased in PP i -treated BMMs, compared to control. (E-H) BMMs were treated with PP i (100-1000) μM then differentiated with RANKL (35 ng) over OsteoAssay discs. (E) Microscopic images of von kossa stained discs, after removal of osteoclasts, show increased number and size of resorption pits in PP i -treated BMMs. Parameters of bone resorptions that include; number of resorption pits (N. pits) (F) , total resorption area (Tt. Ar) (G) , and average pit size per osteoclast (pit Ar) are higher in PP i -treated BMMs, compared to control. Experiments were repeated at least 3 times and showed similar results. N= 6 per group. N= 6 per group. The Mean value is represented in all graphs + SEM. *, p < 0.05; **, p < 0.01. Scale bars , 200 μm.

    Journal: bioRxiv

    Article Title: Inorganic Pyrophosphate Promotes Osteoclastogenic Commitment and Survival of Bone Marrow Derived Monocytes mediated by Egr-1 up-regulation and MITF phosphorylation

    doi: 10.1101/2020.10.01.321976

    Figure Lengend Snippet: (A-D) BMMs were treated with PP i (100-1000) μM then differentiated with RANK-L (35 ng) over human OsteoAssay bone chips and examined for TRAP. (A) Microscopic images show larger TRAP+ osteoclasts (arrows) and less bone chips (asterisk) in PP i -treated BMMs, compared to control. (B) TRAP activity of differentiated osteoclasts are significantly up in PP i -treated BMMs. Parameters of osteoclast function that include; Ca 2+ (C) , and CTX-1 (D) in the CM are increased in PP i -treated BMMs, compared to control. (E-H) BMMs were treated with PP i (100-1000) μM then differentiated with RANKL (35 ng) over OsteoAssay discs. (E) Microscopic images of von kossa stained discs, after removal of osteoclasts, show increased number and size of resorption pits in PP i -treated BMMs. Parameters of bone resorptions that include; number of resorption pits (N. pits) (F) , total resorption area (Tt. Ar) (G) , and average pit size per osteoclast (pit Ar) are higher in PP i -treated BMMs, compared to control. Experiments were repeated at least 3 times and showed similar results. N= 6 per group. N= 6 per group. The Mean value is represented in all graphs + SEM. *, p < 0.05; **, p < 0.01. Scale bars , 200 μm.

    Article Snippet: BMMs were cultured for 48 hours in the OsteoAssay™ Human Bone Plate (Lonza, Walkersville, MD) coated with a thin layer of adherent human bone particles in complete medium containing 25 ng/ml MCSF and PP i (100-1000 μM).

    Techniques: Activity Assay, Staining